...
首页> 外文期刊>The British Journal of Nutrition >Polysaccharide from Gynura divaricata modulates the activities of intestinal disaccharidases in streptozotocin-induced diabetic rats.
【24h】

Polysaccharide from Gynura divaricata modulates the activities of intestinal disaccharidases in streptozotocin-induced diabetic rats.

机译:绞股蓝(Gynura divaricata)的多糖可调节链脲佐菌素诱导的糖尿病大鼠肠道二糖酶的活性。

获取原文
获取原文并翻译 | 示例
           

摘要

During diabetes, structural and functional changes in the alimentary tract are known to take place resulting in an increased absorption of intestinal glucose and alterations in the activities of brush-border disaccharidases. To elucidate the effect of administrating polysaccharide from Gynura divaricata (PGD) on disaccharidase activities, the specific activities of intestinal disaccharidases, namely sucrase, maltase and lactase, were measured in streptozotocin-induced diabetic rats. Normal control and diabetic rats were treated by oral administration with PGD. Specific activities of intestinal disaccharidases were increased significantly during diabetes, and amelioration of the activities of sucrase and maltase during diabetes was clearly visible by the treatment with PGD. However, the increased activity of lactase during diabetes mellitus was remarkably alleviated by the administration of PGD only in the duodenum. Meanwhile, oral sucrose tolerance tests demonstrated that PGD alleviated the hyperglycaemia during diabetes mellitus, resulting from the amelioration in the activities of intestinal disaccharidases. The present investigation suggests that PGD exerted an anti-diabetic effect partly via inhibiting the increased intestinal disaccharidase activities of diabetic rats. This beneficial influence of administration of PGD on intestinal disaccharidases clearly indicates their helpful role in the management of diabetes
机译:在糖尿病期间,已知在消化道中发生结构和功能变化,导致肠道葡萄糖吸收增加,并且刷状双糖酶活性改变。为了阐明施用绞股蓝(Gyura divaricata)多糖(PGD)对糖精酶活性的影响,在链脲佐菌素诱导的糖尿病大鼠中测量了肠糖精酶的比活,即蔗糖酶,麦芽糖酶和乳糖酶。通过口服给予PGD治疗正常对照组和糖尿病大鼠。糖尿病期间肠二糖酶的比活性显着增加,并且通过PGD治疗可以清楚地看到糖尿病期间蔗糖酶和麦芽糖酶活性的改善。然而,仅在十二指肠中施用PGD显着减轻了糖尿病期间乳糖酶的活性增加。同时,口服蔗糖耐量试验表明,PGD减轻了肠道二糖酶活性,从而减轻了糖尿病期间的高血糖症。目前的研究表明,PGD部分通过抑制糖尿病大鼠肠道二糖苷酶活性的增加而发挥抗糖尿病作用。 PGD​​给药对肠道糖酶的这种有益影响清楚地表明了其在糖尿病治疗中的有益作用

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号